The aim is to create artificial hearts using soft robotics that reduce health risks associated with current models.
Development of soft robotic structures
Testing for infection and clotting risks
Evaluating rejection responses to the technology
Prototypes show promise in reducing infection risks
Material choices may lessen clotting issues
Strategies developed to minimize rejection potential
Abstract
Researchers in Europe are attempting to develop soft robotic artificial hearts that overcome the infection, clotting, and rejection risks of today’s technologies